BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30268788)

  • 1. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.
    Doubeni CA; Fedewa SA; Levin TR; Jensen CD; Saia C; Zebrowski AM; Quinn VP; Rendle KA; Zauber AG; Becerra-Culqui TA; Mehta SJ; Fletcher RH; Schottinger J; Corley DA
    Gastroenterology; 2019 Jan; 156(1):63-74.e6. PubMed ID: 30268788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
    Harper DM; Plegue M; Jimbo M; Sheinfeld Gorin S; Sen A
    Elife; 2022 Jun; 11():. PubMed ID: 35762572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
    Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
    Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.
    Lee JK; Jensen CD; Levin TR; Doubeni CA; Zauber AG; Chubak J; Kamineni AS; Schottinger JE; Ghai NR; Udaltsova N; Zhao WK; Fireman BH; Quesenberry CP; Orav EJ; Skinner CS; Halm EA; Corley DA
    Gastroenterology; 2020 Mar; 158(4):884-894.e5. PubMed ID: 31589872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient- and system-related barriers for the earlier diagnosis of colorectal cancer.
    Wahls TL; Peleg I
    BMC Fam Pract; 2009 Sep; 10():65. PubMed ID: 19754964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
    Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA
    Ann Intern Med; 2016 Apr; 164(7):456-63. PubMed ID: 26811150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer.
    Shergill AK; Conners EE; McQuaid KR; Epstein S; Ryan JC; Shah JN; Inadomi J; Somsouk M
    Gastrointest Endosc; 2015 Sep; 82(3):529-37.e1. PubMed ID: 25936449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of colonoscopy and death from colorectal cancer.
    Baxter NN; Goldwasser MA; Paszat LF; Saskin R; Urbach DR; Rabeneck L
    Ann Intern Med; 2009 Jan; 150(1):1-8. PubMed ID: 19075198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.
    Doubeni CA; Weinmann S; Adams K; Kamineni A; Buist DS; Ash AS; Rutter CM; Doria-Rose VP; Corley DA; Greenlee RT; Chubak J; Williams A; Kroll-Desrosiers AR; Johnson E; Webster J; Richert-Boe K; Levin TR; Fletcher RH; Weiss NS
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):312-20. PubMed ID: 23460054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Literature Review and Structured Hybrid Electronic/ Manual Mortality Review to Identify System-Level Improvement Opportunities to Reduce Colorectal Cancer Mortality.
    Schottinger JE; Kanter MH; Litman KC; Lau H; Schwartz GE; Brasfield FM; Alshak NS; Difronzo LA
    Jt Comm J Qual Patient Saf; 2016 Jul; 42(7):303-10. PubMed ID: 27301833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
    Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
    Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Incident Colorectal Cancer and Death After Colonoscopy: A Population-based Study in Utah.
    Samadder NJ; Curtin K; Pappas L; Boucher K; Mineau GP; Smith K; Fraser A; Wan Y; Provenzale D; Kinney AY; Ulrich C; Burt RW
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):279-86.e1-2. PubMed ID: 26343183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death.
    Kaminski MF; Wieszczy P; Rupinski M; Wojciechowska U; Didkowska J; Kraszewska E; Kobiela J; Franczyk R; Rupinska M; Kocot B; Chaber-Ciopinska A; Pachlewski J; Polkowski M; Regula J
    Gastroenterology; 2017 Jul; 153(1):98-105. PubMed ID: 28428142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report.
    Swartz AW; Eberth JM; Strayer SM
    Prev Med; 2019 Jan; 118():104-112. PubMed ID: 30367971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.